<p>PK profiles of HC-070 after intravenous (A) and oral (B) administration in C57BL/6 mice. Plasma concentrations were determined by LC-MS/MS. Points represent the individual concentrations at the times indicated. Lines represent mean exposure (n = 12 mice/arm, n = 3 data points per time point). (C) Summary of PK properties. CL = clearance; V<sub>ss</sub> = volume of distribution at steady state; MRT<sub>disp</sub> = mean residence time of drug molecules after intravascular administration; T<sub>1/2</sub> = half-life. (D) Plasma and brain concentrations measured 2 hours after intravenous or oral administration of 1 or 10 mg/kg HC-070, respectively. C<sub>PL</sub> = concentration in plasma, C<sub>BR</sub> = concentration in brain, K<sub>P,BR...
1. The prediction of human pharmacokinetic (PK) parameters is an important theme to select drug cand...
<p>(A) Concentration change in <sup>13</sup>C-PEGs of different molecular weights (black circles, <s...
<p>t<sub>1/2</sub>, half-life; Ke: elimination rate constant; Tmax: time of peak concentration; Cmax...
<p>Plasma concentration versus time profiles of KMS88009 following IV or PO administration to (A) mi...
<p>Mean plasma concentration-versus-time curve of 7c and 7m after oral administration at 25 mg/kg to...
<p>Pharmacokinetic Parameters of Compounds <b>7c</b> and <b>7m</b> in Male ICR Mice.</p
<p>Compounds were IP administered to fasted C57BL/6J mice at -30 min as described in the <a href="ht...
<p>The plasma concentration-time profiles of Compound 1 after intravenous administration at 180 mg/k...
<p>Plasma was collected over a period of 15 minutes—48 hours after M10 injection and measured by ind...
<p>The plasma concentration-time profiles of Compound 1 after oral administration at 45, 180 and 720...
<p>Serum, brain, and CSF samples were collected at 2 hours after treatment of M084 or vehicle. Conce...
<p>Pharmacokinetic properties of PF-01247324 dosed in C57BL6 mice (n = 3 per dose level).</p
<p>(A) Plasma concentration after 1 IV dose (5 mg/kg in 3 mice per group per time point) decreases w...
<p>Plasma, skin, and intestine samples were collected from the mice orally administered 30 mg/kg Com...
<p>Plasma <b>concentration-time curves</b> of PF-05231023 in DIO mice following a single IV and SC a...
1. The prediction of human pharmacokinetic (PK) parameters is an important theme to select drug cand...
<p>(A) Concentration change in <sup>13</sup>C-PEGs of different molecular weights (black circles, <s...
<p>t<sub>1/2</sub>, half-life; Ke: elimination rate constant; Tmax: time of peak concentration; Cmax...
<p>Plasma concentration versus time profiles of KMS88009 following IV or PO administration to (A) mi...
<p>Mean plasma concentration-versus-time curve of 7c and 7m after oral administration at 25 mg/kg to...
<p>Pharmacokinetic Parameters of Compounds <b>7c</b> and <b>7m</b> in Male ICR Mice.</p
<p>Compounds were IP administered to fasted C57BL/6J mice at -30 min as described in the <a href="ht...
<p>The plasma concentration-time profiles of Compound 1 after intravenous administration at 180 mg/k...
<p>Plasma was collected over a period of 15 minutes—48 hours after M10 injection and measured by ind...
<p>The plasma concentration-time profiles of Compound 1 after oral administration at 45, 180 and 720...
<p>Serum, brain, and CSF samples were collected at 2 hours after treatment of M084 or vehicle. Conce...
<p>Pharmacokinetic properties of PF-01247324 dosed in C57BL6 mice (n = 3 per dose level).</p
<p>(A) Plasma concentration after 1 IV dose (5 mg/kg in 3 mice per group per time point) decreases w...
<p>Plasma, skin, and intestine samples were collected from the mice orally administered 30 mg/kg Com...
<p>Plasma <b>concentration-time curves</b> of PF-05231023 in DIO mice following a single IV and SC a...
1. The prediction of human pharmacokinetic (PK) parameters is an important theme to select drug cand...
<p>(A) Concentration change in <sup>13</sup>C-PEGs of different molecular weights (black circles, <s...
<p>t<sub>1/2</sub>, half-life; Ke: elimination rate constant; Tmax: time of peak concentration; Cmax...